本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Chromocell Therapeutics Corp

13.50
0.0000
成交量:- -
成交額:25.35萬
市值:8,754.76萬
市盈率:-10.88
高:13.50
開:13.50
低:13.50
收:13.50
52周最高:13.50
52周最低:0.4500
股本:648.50萬
流通股本:251.01萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.2405
每股收益(LYR):-1.4271
淨資產收益率:-26.00%
總資產收益率:-188.95%
市淨率:-20.87
市盈率(LYR):-9.46

資料載入中...

2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/04

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/13

SEC問詢函

Form CORRESP - Correspondence
2024/02/13

SEC問詢函

Form CORRESP - Correspondence
2024/02/12

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/12

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/31

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses